chr9-2643916-G-T
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003383.5(VLDLR):c.1023G>T(p.Glu341Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,614,006 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_003383.5 missense
Scores
Clinical Significance
Conservation
Publications
- cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
- cerebellar ataxia, intellectual disability, and dysequilibriumInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_003383.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| VLDLR | NM_003383.5 | MANE Select | c.1023G>T | p.Glu341Asp | missense | Exon 7 of 19 | NP_003374.3 | ||
| VLDLR | NM_001018056.3 | c.1023G>T | p.Glu341Asp | missense | Exon 7 of 18 | NP_001018066.1 | |||
| VLDLR | NM_001322225.2 | c.900G>T | p.Glu300Asp | missense | Exon 6 of 18 | NP_001309154.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| VLDLR | ENST00000382100.8 | TSL:1 MANE Select | c.1023G>T | p.Glu341Asp | missense | Exon 7 of 19 | ENSP00000371532.2 | ||
| VLDLR | ENST00000382099.3 | TSL:1 | c.573G>T | p.Glu191Asp | missense | Exon 3 of 15 | ENSP00000371531.3 | ||
| VLDLR | ENST00000681306.1 | c.1023G>T | p.Glu341Asp | missense | Exon 7 of 18 | ENSP00000506072.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152124Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000239 AC: 6AN: 251332 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000328 AC: 48AN: 1461882Hom.: 0 Cov.: 31 AF XY: 0.0000261 AC XY: 19AN XY: 727244 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152124Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74304 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1023G>T (p.E341D) alteration is located in exon 7 (coding exon 7) of the VLDLR gene. This alteration results from a G to T substitution at nucleotide position 1023, causing the glutamic acid (E) at amino acid position 341 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
not provided Uncertain:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at